Skip to content
socramed

Drug

Benzathine penicillin G

A long-acting intramuscular penicillin preparation whose slow release maintains low serum penicillin levels for weeks, the standard agent for rheumatic fever prophylaxis.

Also called: penicillin G benzathine, BPG

Class
Long-acting benzathine salt of the beta-lactam antibiotic penicillin G
Mechanism
Slow release of penicillin G from the intramuscular depot inhibits bacterial cell-wall peptidoglycan synthesis and kills actively multiplying streptococci.
Main uses
  • Secondary prophylaxis of rheumatic fever and rheumatic heart disease
  • Treatment of group A streptococcal pharyngitis
  • Syphilis and other treponemal infections
Key side effects
  • Pain and swelling at the injection site
  • Allergic reactions, including urticaria and anaphylaxis
  • Rare neurovascular injury when injected near a nerve or artery
Key cautions
  • Deep intramuscular injection only; intravenous injection has caused fatal cardiorespiratory arrest
  • A history of penicillin hypersensitivity is a contraindication
  • Sudden adverse events are rare but reported in patients with severe rheumatic heart disease

Educational use only. This card gives no doses.

Card id: benzathine-penicillin-g

Sources

  • Bicillin L-A (penicillin G benzathine injectable suspension) label. U.S. Food and Drug Administration, 2012. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050141s231lbl.pdf
  • CDC. Clinical Guidance for Acute Rheumatic Fever. 2024. https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/acute-rheumatic-fever.html
  • Marantelli S, Hand R, Carapetis J, Beaton A, Wyber R. Severe adverse events following benzathine penicillin G injection for rheumatic heart disease prophylaxis. Heart Asia. 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC6590992/

Reviewed